BCL-2 Inhibitor and Conventional Chemotherapy Combinations for Acute Myeloid Leukemia: Shifting From the Unfit to the Fit Patient With AML
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details